GLP1R and familial pancreatic carcinoma: Based on the above observations, we hypothesized that the synergistic anti-tumor effects of liraglutide and metformin might resulted from their interactive actions on GLP-1 receptor and/or AMPK signaling activation in the pancreatic cancer cells.